09 Jan Cervical Dystonia Gets FDA Approved Orphan Drug RT002
Revance Therapeutics, Inc is a leading biotechnology company that develops botulinum toxin products used for the treatment of therapeutic conditions. It recently announced that its drug candidate Daxibotulinumtoxin A for injection (RT002) had been granted the orphan drug designation to treat cervical dystonia. Orphan drug designation...